» Articles » PMID: 35964801

Use of Remdesivir in Kidney Transplant Recipients with SARS-CoV-2 Omicron Infection

Citing Articles

Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID-19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta-Analysis.

Lau K, Xiong X, Wong C, Au I, Lui A, Tsai G Influenza Other Respir Viruses. 2024; 18(12):e70065.

PMID: 39722466 PMC: 11669747. DOI: 10.1111/irv.70065.


Remdesivir in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis.

Navidi Z, Pakzad Moghadam S, Iravani M, Orandi A, Orandi A, Ghazi S Clin Transplant Res. 2024; 38(3):212-221.

PMID: 39344698 PMC: 11464156. DOI: 10.4285/ctr.24.0031.


The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study.

Ryu B, Lee J, Lee S Medicine (Baltimore). 2024; 103(29):e39035.

PMID: 39029053 PMC: 11398828. DOI: 10.1097/MD.0000000000039035.


Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2.

Zona E, Gibes M, Jain A, Smith J, Garonzik-Wang J, Mandelbrot D World J Virol. 2024; 13(2):95273.

PMID: 38984080 PMC: 11229845. DOI: 10.5501/wjv.v13.i2.95273.


Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.

Kawashiro K, Suzuki R, Nogimori T, Tsujino S, Iwahara N, Hirose T Sci Rep. 2024; 14(1):12176.

PMID: 38806644 PMC: 11133393. DOI: 10.1038/s41598-024-63147-z.